ASAlejandro Barco S´ánchez

Alejandro Barco S´ánchez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alejandro Barco S´ánchez has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Post sepsis syndrome: an ignored enemy

    by Leydi Tatian Pantoja-Santiago, María Cristina Florian Pérez, Mauricio Sánchez Cano, María del Pilar Marín Giraldo, Yarledy Sthefanny Ariza González, Alejandro Barco Sánchez, José Luis Olivera Ochoa, Jorge Eliécer Gaitán Sánchez, Laura Alejandra Gonzalez, Santiago Mora-Martinez, et al.

    Introduction: post sepsis syndrome is an emerging entity, underrecognized in clinical practice and scarcely described in the literature. It is characterized by physical, cognitive, and psychological sequelae that affect the majority of survivors, with a negative impact on their quality of life and a significant increase in morbidity and mortality and healthcare costs. The objective of this review is to synthesize recent knowledge and evidence available regarding post sepsis syndrome.Method: a narrative review of articles published between 2000 and 2023 in PubMed, Sciencedirect, and LILACS was conducted. The MeSH terms "Sepsis," "Post ICU syndrome," and "Post sepsis syndrome" were used. A total of 221 articles were identified; 84 met inclusion criteria and were analyzed to describe the clinical and pathophysiological manifestations and impact of post sepsis syndrome.Development: the available evidence shows that sepsis survivors present persistent impairment in physical, cognitive, and psychological domains. The syndrome is associated with prolonged immune dysfunction, frequent rehospitalizations, decreased functional autonomy, and increased cardiovascular and neuropsychiatric risk. High mortality rates up to five years after the event and high socioeconomic costs have also been documented. No standardized follow-up protocols or uniform rehabilitation strategies were identified in the reviewed literature.Conclusions: post sepsis syndrome is an underestimated and underdiagnosed problem that represents a clinical and public health challenge. Large-scale studies are needed to define its true epidemiological burden and guide the implementation of multidisciplinary follow-up and rehabilitation programs to reduce its impact on patient survival and quality of life.


  • Open Access

    Hipotensión Permisiva en Trauma

    by Yamileth Estrada Berrío, Alejandro Barco S´ánchez, Sthefanía Ballén Ramírez, Jeimmy Lorena Salazar Bartolo, John Jairo Ocampo Rincón

    Introducción: El shock hemorrágico es una de las causas más comunes de muerte en pacientes con trauma debido a que pone en marcha un círculo vicioso de mecanismos que incluyen hipotermia, acidosis y coagulopatía. Para mitigar estos efectos, se han propuesto estrategias de control de daños, incluido el aporte controlado de líquidos con hipotensión permisiva contemplando metas en la presión arterial sistólica para mantener una adecuada perfusión de los tejidos. Objetivo: Conocer información actualizada acerca del manejo de la hipotensión permisiva en pacientes con trauma. Metodología: Se buscó información en las bases de datos Web-of-Science y Scopus de los últimos cinco años. El resultado arrojó un total de 118 artículos de los cuales se tomaron 30, según los criterios de inclusión y exclusión. Resultados: Todos los artículos consideran el uso de la hipotensión permisiva como una buena opción para el manejo de los pacientes con trauma e hipotensión, sin embargo, difieren en qué momento es adecuado utilizarlo y en qué condiciones se debe realizar. Conclusiones: Si bien la hipotensión permisiva se ha convertido en uno de los pilares fundamentales en el manejo prehospitalario del paciente con trauma, se requieren estudios investigativos en humanos para soportar cuándo y cómo debe utilizarse.